Your browser doesn't support javascript.
loading
Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050): a multicentre, open-label, multicohort, phase 1/2 study.
Gaspar, Nathalie; Venkatramani, Rajkumar; Hecker-Nolting, Stefanie; Melcon, Soledad Gallego; Locatelli, Franco; Bautista, Francisco; Longhi, Alessandra; Lervat, Cyril; Entz-Werle, Natacha; Casanova, Michela; Aerts, Isabelle; Strauss, Sandra J; Thebaud, Estelle; Morland, Bruce; Nieto, Adela Cañete; Marec-Berard, Perrine; Gambart, Marion; Rossig, Claudia; Okpara, Chinyere E; He, Cixin; Dutta, Lea; Campbell-Hewson, Quentin.
Affiliation
  • Gaspar N; Department of Childhood and Adolescent Oncology, Gustave Roussy Cancer Centre, Villejuif, France. Electronic address: nathalie.gaspar@gustaveroussy.fr.
  • Venkatramani R; Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX, USA.
  • Hecker-Nolting S; Klinikum Stuttgart, Olga Hospital, Stuttgart, Germany.
  • Melcon SG; Vall d'Hebron University Hospital, Barcelona, Spain.
  • Locatelli F; Ospedale Pediatrico Bambino Gesù, Sapienza University of Rome, Rome, Italy.
  • Bautista F; Hospital Infantil Universitario Niño Jesus, Madrid, Spain.
  • Longhi A; IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
  • Lervat C; Pediatric and AYA Oncology Unit, Centre Oscar Lambret, Lille, France.
  • Entz-Werle N; Chu Strasbourg-Hôpital Hautepierre, Strasbourg, France.
  • Casanova M; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Aerts I; SIREDO Oncology Center, PSL Research University, Institut Curie, Paris, France.
  • Strauss SJ; University College London Hospital, London, UK.
  • Thebaud E; CHU Nantes-Hôpital Mère-Enfant, Nantes, France.
  • Morland B; Birmingham Children's Hospital, Birmingham, UK.
  • Nieto AC; Hospital Universitario y Politecnico La Fe, Valencia, Spain.
  • Marec-Berard P; Centre Léon Bérard, Lyon, France.
  • Gambart M; CHU de Toulouse, Hôpital des Enfants, Toulouse, France.
  • Rossig C; Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Muenster, Germany.
  • Okpara CE; Eisai, Hatfield, UK.
  • He C; Eisai, Woodcliff Lake, NJ, USA.
  • Dutta L; Eisai, Woodcliff Lake, NJ, USA.
  • Campbell-Hewson Q; The Great North Children's Hospital, Royal Victoria Infirmary, Newcastle Upon Tyne, UK.
Lancet Oncol ; 22(9): 1312-1321, 2021 09.
Article in En | MEDLINE | ID: mdl-34416158
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylurea Compounds / Quinolines / Bone Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Osteosarcoma / Protein Kinase Inhibitors Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2021 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylurea Compounds / Quinolines / Bone Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Osteosarcoma / Protein Kinase Inhibitors Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2021 Document type: Article Country of publication: